Author | Zenz, Thorsten | dc.contributor.author |
Author | Döhner, Hartmut | dc.contributor.author |
Author | Stilgenbauer, Stephan | dc.contributor.author |
Date of accession | 2018-02-09T11:36:39Z | dc.date.accessioned |
Available in OPARU since | 2018-02-09T11:36:39Z | dc.date.available |
Date of first publication | 2011 | dc.date.issued |
Language | en | dc.language.iso |
Publisher | Universität Ulm | dc.publisher |
Keyword | risk genomic aberrations | dc.subject |
Keyword | mutation status | dc.subject |
Keyword | cd38 expression | dc.subject |
Keyword | short survival | dc.subject |
Keyword | features | dc.subject |
Keyword | genes | dc.subject |
Keyword | cyclophosphamide | dc.subject |
Keyword | characterize | dc.subject |
Keyword | fludarabine | dc.subject |
Keyword | deletion | dc.subject |
Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
Title | Chronic Lymphocytic Leukemia: Pathophysiology, Diagnosis and Manifestations, and Prognostic Markers | dc.title |
Resource type | Teil eines Buches | dc.type |
Institution | UKU. Klinik für Innere Medizin III | uulm.affiliationSpecific |
DCMI Type | Text | uulm.typeDCMI |
Category | Publikationsnachweise | uulm.category |
Source - Title of source | Leukemias: Principles and practice of therapy | source.title |
Quellenangabe - Herausgeber | Faderl, S | source.contributor.editor1 |
Quellenangabe - Herausgeber | Kantarjian, H | source.contributor.editor1 |
Source - Publisher | Oxford, England | source.publisherPlace |
Source - Place of publication | Blackwell Science Ltd | source.publisher |
Source - Year | 2011 | source.year |
Source - From page | 299 | source.fromPage |
Source - To page | 307 | source.toPage |
Source - ISBN | 978-1-4443-2736-6 | source.identifier.isbn |
Source - ISBN | 978-1-4051-8235-5 | source.identifier.isbn |
Open Access | No | uulm.OA |
Community | Universitätsklinikum Ulm | uulm.community |
WoS | 000337135300025 | uulm.identifier.wos |
Bibliography | uulm | uulm.bibliographie |